Group One Trading’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-94
| Closed | -$66 | – | 8265 |
|
|
2023
Q4 | $66 | Hold |
94
| – | – | ﹤0.01% | 7216 |
|
|
2023
Q3 | $65 | Hold |
94
| – | – | ﹤0.01% | 7493 |
|
|
2023
Q2 | $225 | Buy |
94
+14
| +18% | +$60 | ﹤0.01% | 7461 |
|
|
2023
Q1 | $650 | Buy |
+80
| New | +$1.06K | ﹤0.01% | 6869 |
|
|
2021
Q2 | – | Sell |
-1,263
| Closed | -$76.9K | – | 8694 |
|
|
2021
Q1 | $83K | Buy |
+1,263
| New | +$98.4K | ﹤0.01% | 5829 |
|
|
2020
Q3 | – | Sell |
-205
| Closed | -$12.2K | – | 6665 |
|
|
2020
Q2 | $8K | Sell |
205
-74
| -27% | -$2.53K | ﹤0.01% | 5237 |
|
|
2020
Q1 | $7K | Buy |
279
+22
| +9% | +$934 | ﹤0.01% | 4698 |
|
|
2019
Q4 | $13K | Sell |
257
-172
| -40% | -$8.34K | ﹤0.01% | 4531 |
|
|
2019
Q3 | $21K | Sell |
429
-483
| -53% | -$34.7K | ﹤0.01% | 4337 |
|
|
2019
Q2 | $83K | Sell |
912
-266
| -23% | -$32.4K | ﹤0.01% | 3491 |
|
|
2019
Q1 | $174K | Buy |
1,178
+216
| +22% | +$41.8K | ﹤0.01% | 2801 |
|
|
2018
Q4 | $151K | Sell |
962
-140
| -13% | -$26.8K | ﹤0.01% | 2894 |
|
|
2018
Q3 | $270K | Buy |
1,102
+771
| +233% | +$183K | ﹤0.01% | 2789 |
|
|
2018
Q2 | $74K | Sell |
331
-398
| -55% | -$107K | ﹤0.01% | 3732 |
|
|
2018
Q1 | $179K | Sell |
729
-44
| -6% | -$11.5K | ﹤0.01% | 2873 |
|
|
2017
Q4 | $238K | Sell |
773
-498
| -39% | -$164K | ﹤0.01% | 2816 |
|
|
2017
Q3 | $465K | Sell |
1,271
-199
| -14% | -$70.6K | ﹤0.01% | 2136 |
|
|
2017
Q2 | $535K | Buy |
1,470
+1,376
| +1,464% | +$412K | 0.01% | 1927 |
|
|
2017
Q1 | $28K | Sell |
94
-154
| -62% | -$38.9K | ﹤0.01% | 3728 |
|
|
2016
Q4 | $55K | Buy |
248
+213
| +609% | +$42.7K | ﹤0.01% | 3218 |
|
|
2016
Q3 | $8K | Buy |
+35
| New | +$7.27K | ﹤0.01% | 4119 |
|
|
2016
Q1 | – | Sell |
-3
| Closed | -$1.07K | – | 5053 |
|
|
2015
Q4 | $1K | Buy |
+3
| New | +$940 | ﹤0.01% | 4629 |
|
|
2015
Q2 | – | Sell |
-30
| Closed | -$9.06K | – | 5259 |
|
|
2015
Q1 | $8K | Sell |
30
-36
| -55% | -$15.5K | ﹤0.01% | 4238 |
|
|
2014
Q4 | $28K | Sell |
66
-9
| -12% | -$2.86K | ﹤0.01% | 3769 |
|
|
2014
Q3 | $24K | Sell |
75
-60
| -44% | -$17.6K | ﹤0.01% | 4017 |
|
|
2014
Q2 | $45K | Buy |
135
+36
| +36% | +$14.1K | ﹤0.01% | 3630 |
|
|
2014
Q1 | $44K | Buy |
+99
| New | +$44.9K | ﹤0.01% | 3722 |
|
Other funds holding DMK
Group One Trading's DMK Position: Q1 2024 in Review
Group One Trading sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 94 shares — an estimated $66 sold.
Group One Trading first reported a position in DMK in Q1 2014 and held it in 27 quarters. The position peaked at $535K in Q2 2017. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.
- Group One Trading reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
- Group One Trading sold 94 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $66.
- Group One Trading first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2014 and held it in 27 quarters.
- Group One Trading's DMK Pharmaceuticals Corporation Common Stock position peaked at $535K in Q2 2017.
- 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.
Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.